Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
79.74
-2.73 (-3.31%)
Feb 21, 2025, 4:00 PM EST - Market closed
Vaxcyte Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for Vaxcyte stock have an average target of 127.71, with a low estimate of 14 and a high estimate of 163. The average target predicts an increase of 60.16% from the current stock price of 79.74.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Vaxcyte stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 5 | 5 | 5 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 1 | 1 | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 9 | 9 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | -82.44% | Feb 11, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Initiates $135 | Strong Buy | Initiates | $135 | +69.30% | Dec 20, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Nov 6, 2024 |
| Needham | Needham | Strong Buy Reiterates $140 | Strong Buy | Reiterates | $140 | +75.57% | Nov 6, 2024 |
| Mizuho | Mizuho | Buy Maintains $113 → $163 | Buy | Maintains | $113 → $163 | +104.41% | Sep 10, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-4.10
from -4.14
EPS Next Year
-4.81
from -4.10
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | n/a | n/a | n/a | |||
| Avg | n/a | n/a | n/a | |||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -3.88 | -3.89 | -2.79 | |||
| Avg | -4.10 | -4.81 | -5.34 | |||
| Low | -4.85 | -6.88 | -8.70 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.